Sean P. Nolan
CIK 1569926 · Chief Executive Officer · last filed 2026-05-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$27.59M
Companies
5
Total Filings
35
Lifetime Open-Market Net
-$1.71M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VTR | Director | 26,181 | $84.60 | $2.21M | $0 | 8 | 2026-05-15 |
| TSHA | Chief Executive Officer | 4,443,802 | $5.71 | $25.37M | -$414.0K | 12 | 2026-01-27 |
| Neurogene Inc. (NLTX) Delisted | Director | — | $13.96 | — | $0 | 2 | 2020-05-07 |
| AveXis, Inc. (AVXS) Delisted | President & CEO | 0 | — | — | -$1.29M | 5 | 2018-05-15 |
| Neurogene Inc. (AQXP) Delisted | Director | — | — | — | $0 | 4 | 2018-05-09 |
Recent Filings · Page 4 of 4
35 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-03-16 | Neurogene Inc. (AQXP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-10-01 | — | Mixed | −65,671 | -$4.86M | |
| 2014-08-14 | — | Mixed | — | -$692.1K | |
| 2013-06-03 | — | Grant (A) | — | $0 | |
| 2013-03-11 | — | Grant (A) | +75,200 | $0 |
Showing 31–35 of 35
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.